Navigation Links
Combination Drugs are the Future of the European Hepatitis B and C Therapeutics Markets, Says Frost & Sullivan
Date:5/1/2013

, NS5a inhibitors, and nucleotide polymerase inhibitors for interferon-free treatment of HCV and Hepatitis B Virus (HBV).

At the same time, wider access to personalised medical treatment is encouraging the uptake of novel, improved therapeutics. The availability of drugs that target viral hepatitis infections according to distinct genetic strains is promoting market development.

HBV and HCV are prevalent among illegal drug users and migrant populations across Europe. However, low awareness means that many affected patients remain untreated.

"Wider access to national counselling programmes and enhancing awareness among high-risk populations such as drug users, infected mothers, and migrants is critical," concludes Chopda. "Such initiatives, together with free screening and reduced treatment costs, will help limit the incidence and impact of Hepatitis B and C."

If you are interested in more information on this research, please send an email to Anna Zanchi , Corporate Communications, at anna.zanchi@frost.com

Analysis of the European Hepatitis B and C Therapeutics Market is part of the Life Sciences Growth Partnership Service programme. Frost & Sullivan's related research services include: European HIV Drugs Market, European Hepatitis B and C Diagnostics Market, U.S. Hepatitis C Market, and U.S HIV/AIDS Therapies Market. All research included in subscriptions provide detailed market opportunities and industry trends that have been evaluated following extensive interviews with market participants.

About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants.

Our "Growth Partnership" supports clients by addressi
'/>"/>

SOURCE Frost & Sullivan
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Telik Announces the Publication of Two Reports in the Journal Of Hematology & Oncology Describing the Results of a Clinical Study of Telintra® in Combination With Revlimid® and a Genomic Study Designed to Identify Genes That Predict Response to Teli
2. Polaris Group Lead Therapeutic Candidate ADI-PEG 20 Demonstrates Potential Anticancer Activity in Various Metastatic Sarcomas and Bladder Cancers That Are Deficient in Key Metabolic Protein, and Enhanced Effects with Combination Therapy in Melanoma
3. Medivir Announces an Interferon-Free Phase II Combination Trial With TMC435 and daclatasvir to Commence Shortly
4. Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
5. Takeda Resubmits New Drug Applications to the United States Food and Drug Administration for Alogliptin and the Fixed-Dose Combination Alogliptin and Pioglitazone
6. American Journal of Medicine Publishes Hypertension Study Comparing the Fixed-Dose Combination of Azilsartan Medoxomil and Chlorthalidone versus Azilsartan Medoxomil Co-administered with Hydrochlorothiazide
7. Hagens Berman Sobol Shapiro LLP and Douglas & London P.C. Announce Proposed Class Action Settlement in Bayer Combination Aspirin Products Litigation
8. Janssen Research & Development Submits New Drug Application to U.S. FDA for Canagliflozin/Metformin Fixed-Dose Combination Therapy to Treat Patients with Type 2 Diabetes
9. Scottsdale Healthcare, TGen study shows Abraxane/gemcitabine combination extends survival of pancreatic cancer patients
10. Takeda Receives FDA Approval for Three New Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations OSENI (alogliptin and pioglitazone) and KAZANO (alogliptin and metformin HCl)
11. OncoGenex Announces Plans for the Initiation of the Borealis-2 Clinical Trial Evaluating OGX-427 in Combination with Second-Line Therapy for Bladder Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... Reportlinker.com announces that a new market research report ... America Aesthetic Lasers and Energy Devices Market Outlook ... North America Aesthetic Lasers and Energy ... GlobalData,s new report, "North America Aesthetic Lasers and ... market data on the North America Aesthetic Lasers ...
(Date:8/28/2014)... YORK , Aug. 28, 2014 ... is available in its catalogue: Germany ... 2020 http://www.reportlinker.com/p02343442/Germany-Aesthetic-Lasers-and-Energy-Devices-Market-Outlook-to-2020.html ... Outlook to 2020 Summary GlobalData,s new ... Outlook to 2020", provides key market data on ...
(Date:8/28/2014)... -- CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – ... - http://photos.prnewswire.com/prnh/20140828/140879 ) The ... Poland " an essential source of information and ... and provides insights into the demographic, regulatory, reimbursement ... provides valuable insights into the trends and segmentation ...
Breaking Medicine Technology:North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 2North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 3North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 4North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 5North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 6North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 7North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 8North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 9North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 10North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 11North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 12North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 13North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 14North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 15North America Aesthetic Lasers and Energy Devices Market Outlook to 2020 16Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 2Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 3Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 4Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 5Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 6Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 7Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 8Germany Aesthetic Lasers and Energy Devices Market Outlook to 2020 9Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5
... 8, 2011 PermaDerm™, an engineered skin substitute which ... prepared from a patient,s own skin cells, has been ... that the U.S. Department of Defense awarded more than ... of the therapeutic candidate for the treatment of severe ...
... a Carmel-headquartered software development and solutions firm has been ... 500 and mid-market businesses throughout the world since 1983. ... its extensive supply chain experience to develop supply chain ... Blue Horseshoe Intellectual Property (BHIP). Led ...
Cached Medicine Technology:PermaDerm™ Receives National Media Coverage 2Software Development Firm's New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain 2Software Development Firm's New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain 3
(Date:8/29/2014)... of Social Work is the recipient of a ... Institute of Drug Abuse (NIDA) at the National Institutes of ... of heroin use. Additionally, the grant provides resources to create ... , Heroin use has increased steadily since 2007 according to ... the cheaper and more available opioid. , A primary ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 "After reading a ... don’t stand very often, I decided that there needed to ... during the day," said a concerned inventor from Sikestons, Mo. ... for long periods. It builds endurance and keeps the user ... health. Easy to use and producible in design variations, it's ...
(Date:8/29/2014)... have been hospitalized for a burn as a child experience ... to new research at the University of Adelaide . ... been conducted by the University,s Centre for Traumatic Stress Studies. ... some form of mental illness and 30% suffered depression at ... in the journal Burns , also found ...
(Date:8/29/2014)... across the Arabian Peninsula and spread to Europe several ... of several hundred people since its discovery in 2012. ... how easily the pathogen spreads from human to human. ... the University of Bonn have now come to the ... transmission is low. Still, a third of infected persons ...
(Date:8/29/2014)... Pittsburgh, PA (PRWEB) August 29, 2014 ... from Cooper City, Fla., understands that there’s a direct ... in the knees, hips and back. "Since conventional shoe ... to design a solution of my own," he said. ... Sole Orthotic provides better support for the foot in ...
Breaking Medicine News(10 mins):Health News:$1.25 million NIH grant to aid research on impact of heroin use 2Health News:Intervention needed for survivors of childhood burns 2Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3
... women, including the growing number who choose later-in-life pregnancy, ... their menopause and infertility is critically important. , ... new information about hormonal biomarkers that can address ... the end, this information can change the way we ...
... The University of,Rochester Medical Center (URMC) today ... (CTSB) -- a facility that will help,accelerate scientific ... cure diseases., Earlier this year, Governor David ... that state would provide $50 million,toward the construction ...
... On Tuesday, October 28th a group of,bicyclists will leave ... their,80 mile journey to raise money and awareness for cancer ... The destination point of the ride is the Hooters ... by Hooters General Manager Jeff Spraker,took to the road for ...
... Inc. (DCI),announced today that it has completed the ... (pancrelipase), used in the treatment,of Exocrine Pancreatic Insufficiency ... The FDA had previously granted the product Fast,Track ... "Digestive Care has provided vital products used ...
... Brandi Chastain and Kerri Strug support youth, fitness and ... Run Series guides runners on the path ... Global financial services,leader ING celebrates its sixth year as title ... Sunday, November 2. In addition to,painting the Big Apple "Orange" ...
... The Georgia Pecan Commission has,launched "Georgia Pecans Fit! ... eating habits. It is being promoted with new,findings ... the health benefits of eating pecans and breakfast,recipes ... view the Multimedia News Release, go to:, http://www.prnewswire.com/mnr/georgiapecancommission/35429/ ...
Cached Medicine News:Health News:New hormone data can predict menopause within a year 2Health News:URMC Breaks Ground for New Translational Research Institute 2Health News:URMC Breaks Ground for New Translational Research Institute 3Health News:URMC Breaks Ground for New Translational Research Institute 4Health News:URMC Breaks Ground for New Translational Research Institute 5Health News:Hooters to Hooters 80 Mile Bicycle Ride Supporting Local American Cancer Society Unit 2Health News:Digestive Care, Inc. Announces the Complete Submission of the NDA for PANCRECARB(R) (pancrelipase) 2Health News:ING Promotes 'Physical and Fiscal Fitness' During ING New York City Marathon 2008 2Health News:ING Promotes 'Physical and Fiscal Fitness' During ING New York City Marathon 2008 3Health News:ING Promotes 'Physical and Fiscal Fitness' During ING New York City Marathon 2008 4Health News:Photos: Georgia Pecan Campaign Emphasizes Nutritional Importance of Breakfast 2
Quatroloc Revision Hip System...
A stable revision design with extensive sizes...
Severe revision options for the knee and hip...
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem....
Medicine Products: